ResearcherFirst Hospital of China Medical UniversityNo recent work listed
Gang Ma
Matched on ORCID iD 0000-0001-5270-8666; OpenAlex author ID A5030596112. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2019: 1 paper · 2020: none · 2021: 3 papers · 2022: none · 2023: 1 paper
Papers 5
- Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer. Co-author DOI 10.1016/j.cytogfr.2023.07.006↗
- Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. Co-author DOI 10.1038/s41419-021-03938-8↗
- Long non-coding RNA ELFN1-AS1 in the pathogenesis of pancreatic cancer. Co-author DOI 10.21037/atm-21-2376↗
- The Role of Long Noncoding RNA AL161431.1 in the Development and Progression of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.666313↗
- Inactivation of ATF-2 enhances epithelial-mesenchymal transition and gemcitabine sensitivity in human pancreatic cancer cells. Co-author DOI 10.1002/jcb.27734↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shaowei Song · 4 shared papers, 2019–2021 · strength 0.56
- Paper Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. DOI 10.1038/s41419-021-03938-8↗
- Paper The Role of Long Noncoding RNA AL161431.1 in the Development and Progression of Pancreatic Cancer. DOI 10.3389/fonc.2021.666313↗
- Paper Long non-coding RNA ELFN1-AS1 in the pathogenesis of pancreatic cancer. DOI 10.21037/atm-21-2376↗
- Kejian Guo · 3 shared papers, 2021 · strength 0.44
- Paper Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. DOI 10.1038/s41419-021-03938-8↗
- Paper The Role of Long Noncoding RNA AL161431.1 in the Development and Progression of Pancreatic Cancer. DOI 10.3389/fonc.2021.666313↗
- Paper Long non-coding RNA ELFN1-AS1 in the pathogenesis of pancreatic cancer. DOI 10.21037/atm-21-2376↗
- Zhe Liu · 2 shared papers, 2021–2023 · strength 0.34
- Yuanhong Xu · 2 shared papers, 2021 · strength 0.29
- Zhe Liu · 2 shared papers, 2021 · strength 0.29
- Jin Long · 1 shared paper, 2023 · strength 0.19
- Wei Guo · 1 shared paper, 2023 · strength 0.19
- Yuanhong Xu · 1 shared paper, 2021 · strength 0.15
- Xingda Wu · 1 shared paper, 2019 · strength 0.12
- Zhe Liu · 1 shared paper, 2019 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.